EUVIMEDEUVIMED entdecken
Crossref

The risks of hepatocellular carcinoma and variceal bleeding after HCV eradication with direct-acting antiviral therapy: a propensity score analysis

Anca Trifan

Revista Medico-Chirurgicala · 2021

DOI: 10.22551/msj.2021.01.08 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Medico-Chirurgicala, 2021. Verfasst von Anca Trifan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The combination paritaprevir/ritonavir, ombitasvir, and dasabuvir (PrOD), which achieves a high sustained virologic response (SVR) rate and few side effects, has dramatically changed the outcome of hepatitis C virus (HCV) infection. The risk of hepatocellular carcinoma (HCC) and variceal bleeding in patients treated with interferon (IFN)-free direct-acting antivirals (DAAs) is unknown. The aim of this prospective study was to evaluate the rate of HCC and variceal bleeding and identify prognostic factors for decompensation/complications in HCV-1b-infected patients with compensated liver cirrhosis following treatment with PrOD with or without ribavirin. Material and methods: A total of 483 HCV patients received PrOD treatment. Patients with a history of HCC were excluded from the study. Prior antiviral therapy was identified in 59% of patients. Patient data were collected at baseline, at the end of treatment (EoT), at 3 months after EOT (SVR) and during an 18-month surveillance period. Patients were divided into two age groups:

Zitieren

APA

Trifan, A. (2021). The risks of hepatocellular carcinoma and variceal bleeding after HCV eradication with direct-acting antiviral therapy: a propensity score analysis. Revista Medico-Chirurgicala. https://doi.org/10.22551/msj.2021.01.08

Vancouver

Trifan A. The risks of hepatocellular carcinoma and variceal bleeding after HCV eradication with direct-acting antiviral therapy: a propensity score analysis. Revista Medico-Chirurgicala. 2021. doi:10.22551/msj.2021.01.08

BibTeX
@article{Trifan2021,
  author = {Trifan, Anca},
  title = {The risks of hepatocellular carcinoma and variceal bleeding after HCV eradication with direct-acting antiviral therapy: a propensity score analysis},
  journal = {Revista Medico-Chirurgicala},
  year = {2021},
  doi = {10.22551/msj.2021.01.08}
}
Kostenlos starten →